Citizens National Bank Trust Department’s Novo Nordisk NVO Stock Holding History

Citizens National Bank Trust Department’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.1K	Buy	420 +120	+40%	+$5.16K	﹤0.01%	309
2026 Q1	$11K	Hold	300	–	–	﹤0.01%	333
2025 Q4	$15.3K	Hold	300	–	–	﹤0.01%	321
2025 Q3	$16.6K	Hold	300	–	–	﹤0.01%	321
2025 Q2	$20.7K	Hold	300	–	–	﹤0.01%	299
2025 Q1	$20.8K	Hold	300	–	–	﹤0.01%	300
2024 Q4	$25.8K	Hold	300	–	–	0.01%	259
2024 Q3	$35.7K	Hold	300	–	–	0.01%	239
2024 Q2	$42.8K	Hold	300	–	–	0.01%	228
2024 Q1	$38.5K	Hold	300	–	–	0.01%	233
2023 Q4	$31K	Hold	300	–	–	0.01%	231
2023 Q3	$27.3K	Hold	300	–	–	0.01%	237
2023 Q2	$24.3K	Hold	300	–	–	0.01%	248
2023 Q1	$23.9K	Hold	300	–	–	0.01%	239
2022 Q4	$20K	Hold	300	–	–	0.01%	247
2022 Q3	$15K	Hold	300	–	–	﹤0.01%	262
2022 Q2	$17K	Hold	300	–	–	﹤0.01%	261
2022 Q1	$17K	Hold	300	–	–	0.01%	244
2021 Q4	$17K	Buy	+300	New	+$16.3K	0.01%	247

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Citizens National Bank Trust Department's NVO Position: Q2 2026 in Review

Citizens National Bank Trust Department increased its Novo Nordisk (NVO) stake by 40% in Q2 2026, buying an estimated $5.16K and bringing the position to 420 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #309.

Citizens National Bank Trust Department first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $42.8K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Citizens National Bank Trust Department held 420 shares of Novo Nordisk worth $20.1K as of Q2 2026.
Citizens National Bank Trust Department bought 120 Novo Nordisk shares in Q2 2026, an estimated $5.16K.
Novo Nordisk made up ﹤0.01% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #309 holding.
Citizens National Bank Trust Department first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
Citizens National Bank Trust Department's Novo Nordisk position peaked at $42.8K in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.